Molecular regulation, membrane association and secretion of tumor cathepsin B

APMIS

Volumn 107, Issue 1, 1999, Pages 28-37

  Frosch, Barbara A ^d   Berquin, Isabelle ^a,c   Emmert Buck, Michael R ^b   Moin, Kamiar ^d   Sloane, Bonnie E ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d NONE

Author keywords

Cathepsin B; Cysteine protease; Membrane protease; Molecular regulation; Secretion

Indexed keywords

CATHEPSIN B; CYSTEINE PROTEINASE; PROTEINASE;

BREAST CARCINOMA; CANCER INVASION; CARCINOGENESIS; CARDIA CARCINOMA; COLORECTAL CANCER; ENDOCYTOSIS; ENZYME ACTIVITY; EXOCYTOSIS; HUMAN; INTRACELLULAR TRANSPORT; LUNG CARCINOMA; METASTASIS POTENTIAL; OSTEOCLASTOMA; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN SECRETION; PROTEIN SYNTHESIS REGULATION; REVIEW; TRANSPORT KINETICS;

EID: 0003126050     PISSN: 09034641     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1699-0463.1999.tb01523.x     Document Type: Review

References (65)

1. 1. Liotta LA, Stetler-Stevenson WG. Tumor invasion and metastasis: an imbalance of positive and negative regulation. Cancer Res 1991; 51(18 Suppl): 5054S-9S.
2. 2. Ren W-P, Sloane BF. Cathepsins D and B in breast cancer. In: Adv Cell Mol Biol Breast Cancer: Mammary Tumor Cell Cycle, Differentiation, and Metastasis. Dickson RD, Lippman ME, editors (Kluwer, Boston), 1996; pp 325-52.
3. 3. Yan S-Q, Sameni M, Sloane BF. Cathepsin B and human tumor progression. Biol Chem 1998;379:113-23.
4. 4. Emmert-Buck MR, Roth MJ, Zhuang Z, Campo E, Rozhin J, Sloane BF, Liotta LA, Stetler-Stevenson WG. Increased gelatinase A (MMP-2) and cathepsin B activity in microdissected human colon cancer. Am J Pathol 1994;145:1285-90.
5. 5. Campo E, Munoz J, Miquel R, Palacin A, Cardesa A, Sloane B, Emmert-Buck M. Cathepsin B expression in colorectal carcinomas correlates with tumor progression and shortened patient survival. Amer J Pathol 1994;145:301-9.
6. 6. Shuja S, Murnane MJ. Marked increase in cathepsin B and L activities distinguish papillary carcinoma of the thyroid from normal thyroid or thyroid with non-neoplastic disease. Int J Cancer 1996; 66(4): 420-6.
7. 7. Buck MR, Karustis DG, Day NA, Honn KV, Sloane BF. Degradation of extracellular-matrix proteins by human cathepsin B from normal and tumour tissues. Biochem J 1992;282:273-8.
8. 8. Wang X, Chan SJ, Eddy RL, Byers MG, Fukushima Y, Henry WM, Haley LL, Steiner DF, Shows TB. Chromosome assignment of cathepsin B (CTSB) to 8p22 and cathepsin H (CTSH) to 15q24-q25. Cytogenet Cell Gene 1988;59:710-11.
9. 9. Fong D, Chan MM-Y, Hseih W-T, Menninger JC, Ward DC. Confirmation of the human cathepsin B gene (CTSB) assignment to chromosome 8. Hum Genet 1992;89:10-12.
10. 10. Qian F, Frankfater A, Chan SJ, Steiner DF. The structure of the mouse cathepsin B gene and its putative promoter. DNA Cell Biol 1991;12:299-309.
11. 11. Gong Q, Cahn SJ, Bajkowski AS, Steiner DF, Frankfater A. Characterization of the cathepsin B gene and multiple mRNAs in human tissues: Evidence for alternative splicing of cathepsin B pre-mRNA. DNA Cell Biol 1993;12:299-309.
12. 12. Berquin IM, Cao L, Fong D, Sloane BF. Identification of two new exons and multiple transcription start points in the 5′-untranslated region of the human cathepsin-B-encoding gene. Gene 1995;159:143-9.
13. 13. Hizel C, Ferrara M, Cure H, Pezet D, Dechelotte P, Chipponi J. Evaluation of the 5′ spliced form of human cathepsin B mRNA in colorectal mucosa and tumors. Oncology Reports 1998;5:31-4.
14. 14. Cavailles V, Augereau P, Rochefort H. Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells. Proc Natl Acad Sci USA 1993; 90(1): 203-7.
15. 15. Pagano M, Dalet-Fumerson V, Engler R. The glycosylation state of the precursors of the cathepsin B-like proteinases from human malignant ascitic fluid: possible implications in the secretory pathway of these proenzymes. Cancer Lett 1989;45:13-9.
16. 16. Cao L, Taggart RT, Berquin IM, Moin K, Fong D, Sloane BF. Human gastric adenocarcinoma cathepsin B: isolation and sequencing of full-length cDNAs and polymorphisms of the gene. Gene 1994;139:163-9.
17. 17. Hanewinkel H, Glossl J, Kresse H. Biosynthesis of cathepsin B in cultured normal and I-cell fibroblasts. J Biol Chem 1987;268:1941-6.
18. 18. von Figura K, Hasilik A. Lysosomal enzymes and their receptors. Ann Rev Biochem 1986;55:167-93.
19. 19. Dahms NM, Lobel P, Kornfeld S. Mannose 6-phosphate receptor dependent secretion of lysosomal enzymes. EMBO J 1989;9:3507-13.
20. 20. Kornfeld S, Mellman I. The biogenesis of lysosomes. Annu Rev Cell Biol 1989;5:483-525.
21. 21. Kornfeld S. Lysosomal enzyme targeting. Biochem Soc Trans 1990;18:367-74.
22. 22. McIntyre G, Erickson AH. Procathepsins L and D are membrane-bound in acidic microsomal vesicles. J Biol Chem 1991;266:15438-45.
23. 23. McIntyre G, Erickson AH. The lysosomal proenzyme receptor that binds procathepsin L to microsomal membranes at pH 5 is a 43-kDa integral membrane protein. Proc. Natl Acad Sci USA 1993; 90(22): 10588-92.
24. 24. McIntyre GF, Godbold GD, Erickson AH. The pH-dependent membrane association of procathepsin L is mediated by a 9-residue sequence within the propeptide. J Biol Chem 1994;269:567-72.
25. 25. Tapper H, Sundler R. Role of lysosomal and cytosolic pH in the regulation of macrophage lysosomal enzyme secretion. Biochem J 1990;272:407-14.
26. 26. Mathieu M, Vignon F, Capony F, Rochefort H. Estradiol down-regulates the mannose 6-phosphate/insulin-like growth factor-H receptor gene and induces cathepsin D in breast cancer cells: a receptor saturation mechanism to increase the secretion of lysosomal proenzymes. Mol Endocrinol 1991;5:815-22.
27. 27. Weiss RE, Liu BC, Ahlering T, Dubeau, L, Droller MJ. Mechanisms of human bladder tumor invasion: role of protease cathepsin B. J Urol 1990;144:798-804.
28. 28. Sloane BF, Moin K, Sameni M, Tait LR, Rozhin J, Ziegler G. Membrane association of cathepsin B can be induced by transfection of human breast epithelial cells with c-Ha-ras oncogene. J Cell Sci 1994;107:373-84.
29. 29. Sloane BF, Sameni M, Cao L, Berquin I, Rozhin J, Ziegler G, Moin K, Day NA. Alterations in processing and trafficking of cathepsin B during malignant progression. In: Katanuma N, Suzuki K, Travis J, Fritz H, editors. Biological functions of proteases and inhibitors. Scientific Societies Press, Tokyo, Japan. 1994;131-47.
30. 30. Sameni M, Elliott E, Ziegler G, Fortgens PH, Dennison C, Sloane BF. Cathepsins B and D are localized at surface of human breast cancer cells. Pathol Oncol Res. 1995;1:43-53.
31. 31. Tooze J, Hollinshead M, Hensel G, Kern HF, Hoflack B. Regulated secretion of mature cathepsin B from rat exocrine pancreatic cells. Eur J Cell Biol 1991;56:187-200.
32. 32. Hashizume Y, Waguri S, Watanabe T, Kominami E, Uchiyama Y. Cysteine proteinases in rat parathyroid cells with special reference to their correlation with parathyroid hormone in storage granules. J Histochem Cytochem 1993;41:273-82.
33. 33. Heuser J. Changes in lysosomal shape and distribution correlated with changes in cytoplasmic pH. J Cell Biol 1989;108:855-64.
34. 34. Rozhin J, Sameni M, Ziegler G, Sloane BF. Pericellular pH affects distribution and secretion of cathepsin B in malignant cells. Cancer Res 1994;54:6517-25.
35. 35. Silver IA, Murrills RJ, Etherington DJ. Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. Exp Cell Res 1988;175: 266-76.
36. 36. Young PR. Spevacek SM. Substratum acidification by murine B16F10 melanoma cultures. Biochim Biophys Acta 1992;1139:163-6.
37. 37. Young PR. Spevacek SM. Substratum acidification and proteinase activation by murine B16F10 melanoma cultures. Biochim Biophys Acta 1993;1182:69-74.
38. 38. Montcourrier P, Mangeat PH, Valembois C, Salazar G, Sahuquet A, Duperray C, Rochefort H. Characterization of very acidic phagosomes in breast cancer cells and their association with invasion. J Cell Sci 1994;107:2381-91.
39. 39. Honn KV, Timar J, Rozhin J, Bazaz R, Sameni M, Ziegler G, Sloane BF. A lipoxygenase metabolite, 12-S-HETE, stimulates protein kinase c-mediated release of cathepsin B from malignant cells. Exp Cell Res 1994;214:120-30.
40. 40. Sloane BF, Rozhin J, Gomez AP, Grossi TM, Honn KV. Effects of 12-hydroxyeicosatetraenoic acid on release of cathepsin B and cysteine proteinase inhibitors from malignant melanoma cells. In: Honn KV, Marnett LJ, Migam S, Walden TL, editors. Eicosanoids and other bioreactive lipids in cancer and radiation injury. Kluwer Press, Boston. 1991;373-7.
41. 41. Chopra H, Timar J, Chen YQ, Rong X, Grossi IM, Fitzgerald LA, Taylor JD, Honn KV. The lipoxygenase metabolite 12(S)-HETE induces a cytoskeleton-dependent increase in surface expression of integrin alpha IIb beta 3 on melanoma cells. Intl J Cancer 1991;49:774-86.
42. 42. Silletti S, Timar J, Honn KV, Raz A. Autocrine motility factor induces differential 12-lipoxygenase expression and activity in high-and low-metastatic K1735 melanoma cell variants. Cancer Res 1994;54(22):5752-6.
43. 43. Watanabe M, Higashi T, Hashimoto M, Tomoda I, Tominaga S, Hashimoto M, Morimoto S, Yamauchi Y, Nakatsukasa H, Kobayashi M, Watanabe A, Hagashima H. Elevation of tissue cathepsin B and L activities in gastric cancer. Hepato-gastroenterol 1987;4:120-2.
44. 44. Watanabe M, Higashi T, Watanabe A, Osawa T, Sato Y, Kimura Y, Tominaga S, Hashimoto M, Yoshida Y, Morimoto S, Shiota T, Hasinoto M, Kobayashi M, Tomoda J, Tsuji T. Cathepsin B and L activities in gastric cancer tissue: correlation with histological findings. Biochem Med Metabol Biol 1989;42:21-9.
45. 45. Krepela E, Kasafirek E, Novak K, Viklicky J. Increased cathepsin B activity in human lung tumors. Neoplasma 1990;37:61-70.
46. 46. Werle B, Ebert W, Klein W, Spiess, E. Assessment of cathepsin L activity by use of the inhibitor CA-074 compared to cathepsin B activity in human lung tumor tissue. Biol Chem Hoppe-Seyler 1995;376:157-64.
47. 47. Ebert W, Knoch H, Werle B, Trefz G, Muley T, Spiess E. Prognostic value of increased lung tumor tissue cathepsin B. Anticancer Res 1994;14:895-900.
48. 48. Shuja S, Sheahan K, Murnane MJ. Cysteine endopeptidase activity levels in normal human tissues, colorectal adenomas and carcinomas. Int J Cancer 1991;49:341-6.
49. 49. Sheahan K, Shuja S, Murnane MJ. Cysteine protease activities and tumor development in human colorectal carcinoma. Cancer Res 1989;49:3809-14.
50. 50. Murnane MF, Sheahan K, Ozdemirli M, Shuja S. Stage-specific increases in cathepsin B messenger RNA content in human colorectal carcinoma. Cancer Res 1991;51:1137-42.
51. 51. Page AE, Warburton MJ, Chambers TJ, Pringle JAS, Hayman AR. Human osteoclastomas contain multiple forms of cathepsin B. Biochim Biophys Acta 1991;1116:57-66.
52. 52. Krepela E, Vicar J, Cernoch V. Cathepsin B in human breast tumor tissue and cancer cells. Neoplasma 1989;36:41-52.
53. 53. Lah TT, Calef G, Kalman E, Shinde BG, Russo J, Jarosz D, Zabrecky J, Somers R, Daskal I. Cathepsins D, B and L in breast carcinoma and in transformed human breast epithelial cells (HBEC). Biol Chem Hoppe-Seyler 1995;376:357-63.
54. 54. Lah TT, Kokalj-Kunovar M, Strukelj B, Pungercar J, Barlic-Maganja D, Drobnic-Kosorok M, Kastelic L, Babnik J, Golouh R, Turk V. Stefins and lysosomal cathepsins B, L and D in human breast carcinoma. Int J Cancer 1992;50:36-44.
55. 55. Recklies AD, Poole AR, Mort JS. A cysteine proteinase secreted from human breast tumours is immunologically related to cathepsin B. Biochem J 1982;207:633-6.
56. 56. Rempel SA, Rosenblum ML, Mikkelsen T, Van P-S, Ellis KD, Golembieski WA, Sameni M, Rozhin J, Ziegler G, Sloane BF. Cathepsin B expression and localization in glioma progression and invasion. Cancer Res 1994;54:6027-31.
57. 57. Sivaparvathi M, Sawaya R, Wang SW, Rayfor A, Yamamoto M, Liotta LA, Nicolson GL, Rao JS. Overexpression and localization of cathepsin B during the progression of human gliomas. Clin Exp Metast 1995;13:49-56.
58. 58. Tsushima H, Yoshida HE, Ueki Y, Hopsu-Havu VK. Inactive cathepsin B-like enzyme in human melanoma culture medium. Melanoma Res 1991;1:341-7.
59. 59. Frohlich E, Schaumburg-Lever S, Klessen C. Immunocytochemical and immunoelectron microscopic demonstration of cathepsin B in human malignant melanoma. Br J Dermatol 1995;132:867-75.
60. 60. Sinha AA, Wilson MJ, Gleason DF, Reddy PK, Sameni M, Sloane BF. Immunohistochemical localization of cathepsin B in neoplastic human prostate. Prostate 1995;26:171-8.
61. 61. Terada T, Ohta T, Minato H, Nakanuma Y. Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and hepatocellular carcinomas. Hum Pathol 1995;26:746-52.
62. 62. Sinha AA, Gleason DF, Limas C, Reddy PK, Wick MR, Hagen KA, Wilson MJ. Localization of cathepsin B in normal and hyperplastic human prostate by immunoperozidase and protein A-gold techniques. Anat Rec 1989;223:266-75.
63. 63. Poole AR, Tiltman JK, Recklies AD, Stoker TAM. Differences in secretion of the proteinase cathepsin B at the edges of human breast carcinomas and fibroadenomas. Nature 1978;273:545-7.
64. 64. Visscher DW, Sloane BF, Sameni M, Babiarz JW, Jacobson J, Crissman JD. Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia. Mod Path 1994;7:76-81.
65. 65. Sloane BF, Rozhin J, Johnson K, Taylor H, Crissman JD, Honn KV. Cathepsin B: association with plasma membrane in metastatic tumors. Proc Natl Acad Sci USA 1986;83:2483-7.